Quartz
US · 17 mins ago
Kailera's oral weight loss pill met its trial goal, but nausea hit 70% of patients
Kailera stock dropped 10% after Phase 3 data showed roughly 70% of patients on HRS-7535 experienced nausea
Do you trust Quartz?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!